You just read:

aTyr Pharma Receives FDA Fast Track Designation for Resolaris™ to Treat Facioscapulohumeral Muscular Dystrophy (FSHD)

News provided by

aTyr Pharma, Inc.

24 Oct, 2016, 08:00 ET